Therapeutic Asset Ratings
6,308 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
azd3632
Acute Myeloid Leukemia
AstraZeneca
P1/2
CCC
(48)
azd4360
Gastroesophageal Junction Adenocarcinoma
AstraZeneca
P1/2
CCC
(48)
azd4512
B-Cell Acute Lymphoblastic Leukemia
AstraZeneca
P1/2
CCC
(48)
AZD 5153
Acute Myeloid Leukemia
Beat AML, LLC
P1/2
CCC
(48)
azd5305
Biliary Tract Cancer
AstraZeneca
P1/2
CCC
(48)
azd5863
Gastroesophageal Junction Adenocarcinoma
AstraZeneca
P1/2
CCC
(48)
azd6750
Skin Squamous Cell Carcinoma
AstraZeneca
P1/2
CCC
(48)
azd8421
Estrogen-Receptor Positive Breast Cancer
AstraZeneca
P1/2
CCC
(48)
azd8853
Urinary Bladder Neoplasm
AstraZeneca
P1/2
CCC
(48)
Azeliragon
Breast Cancer
Georgetown University
P1/2
CCC
(48)
Baff-R Car-T
Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
Baff-R Car-T
Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
Baff-R Car-T
Waldenstrom Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
Balstilimab
Digestive System Cancer
Rottapharm Biotech
P1/2
CCC
(48)
Balstilimab
Head And Neck Squamous Cell Carcinoma
ImmunoGenesis
P1/2
CCC
(48)
bat1006
Cancer
Bio-Thera Solutions
P1/2
CCC
(48)
bat4706
Cancer
Bio-Thera Solutions
P1/2
CCC
(48)
bat8006 for
Ovarian Carcinoma
Bio-Thera Solutions
P1/2
CCC
(48)
Bbt-207
Non-Small Cell Lung Carcinoma
Bridge Biotherapeutics, Inc.
P1/2
CCC
(48)
bc1 cell line
Breast Neoplasm
BriaCell Therapeutics Corporation
P1/2
CCC
(48)
Bcma-Cart Cells
Plasmacytoma
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
Bcma-Cart Cells
Refractory Malignant Neoplasm
Institute of Hematology & Blood Diseases Hospital, China
P1/2
CCC
(48)
Bcma Car-T Cells
Plasma Cell Neoplasm
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
Bcma Targeted Prime Car-T Cells
Plasma Cell Neoplasm
Chongqing Precision Biotech Co., Ltd
P1/2
CCC
(48)
Beam-201
Acute Lymphoblastic Leukemia
Beam Therapeutics Inc.
P1/2
CCC
(48)
Showing 851 to 875 of 6,308 assets
Previous
Page 35 of 253
Next